January 26, 2017
Senior associate Katie Bond was quoted in the Natural Products Insider article “Lawyers: Republican-Led FTC Positive Sign for Dietary Supplements.” The article notes that lawyers in Washington and New York said they expect a policy shift at the Commission that could benefit businesses — including marketers of dietary supplements. Ms. Bond noted that the FTC’s standard of two RCTs, or human clinical trials, is rooted in the policies of David Vladeck, the former director of the Commission’s Bureau of Consumer Protection, who was appointed by former FTC Chair Jon Leibowitz. She also mentioned that Vladeck’s successor, Jessica Rich, has maintained the same policies and litigation strategy. Ms. Bond went on to say that under the new administration, FTC’s advertising guidance for the dietary supplement industry will remain in effect. “But I think just under this administration, you are going to see actual enforcement of that guidance as it exists," she said, “and not an effort to raise the standard or move beyond that guidance."
To read the full article, please click here.